What stood out in the results was that downregulation of MT1A, MT1B, MT1H, MT1X, MT2A, and MT4 was significantly correlated with poor OS in patients with HCC (Figures 3A,B,F,H,I,K). This evidence concerns the gene MT4 and hepatocellular carcinoma.